These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20606740)

  • 21. Hepatitis B: liver fibrosis and hepatocellular carcinoma.
    Lok AS
    Gastroenterol Clin Biol; 2009; 33(10-11):911-5. PubMed ID: 19577871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of miR-212 and Other Biomarkers in the Diagnosis and Treatment of HBV-infection-related Liver Diseases.
    Zhang Y; Xi H; Nie X; Zhang P; Lan N; Lu Y; Liu J; Yuan W
    Curr Drug Metab; 2019; 20(10):785-798. PubMed ID: 31608838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cirrhosis has no impact on therapeutic responses of entecavir for chronic hepatitis B.
    Wang PC; Wei TY; Tseng TC; Lin HH; Wang CC
    Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):946-950. PubMed ID: 28538267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum biomarkers of hepatitis B virus infected liver inflammation: a proteomic study.
    He QY; Lau GK; Zhou Y; Yuen ST; Lin MC; Kung HF; Chiu JF
    Proteomics; 2003 May; 3(5):666-74. PubMed ID: 12748946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease.
    Gray J; Chattopadhyay D; Beale GS; Patman GL; Miele L; King BP; Stewart S; Hudson M; Day CP; Manas DM; Reeves HL
    BMC Cancer; 2009 Aug; 9():271. PubMed ID: 19656391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telbivudine on IgG-associated hypergammaglobulinemia and TGF-β1 hyperactivity in hepatitis B virus-related liver cirrhosis.
    Ho CH; Chang TT; Chien RN
    PLoS One; 2019; 14(11):e0225482. PubMed ID: 31770396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between serum HBV DNA levels and hepatic fibrosis markers in chronic hepatitis B].
    Dong Z; Shen H; Zhang FK
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):129-31. PubMed ID: 17653313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases.
    Oliveri F; Coco B; Ciccorossi P; Colombatto P; Romagnoli V; Cherubini B; Bonino F; Brunetto MR
    World J Gastroenterol; 2008 Oct; 14(40):6154-62. PubMed ID: 18985805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure.
    Wu T; Li J; Shao L; Xin J; Jiang L; Zhou Q; Shi D; Jiang J; Sun S; Jin L; Ye P; Yang L; Lu Y; Li T; Huang J; Xu X; Chen J; Hao S; Chen Y; Xin S; Gao Z; Duan Z; Han T; Wang Y; Gan J; Feng T; Pan C; Chen Y; Li H; Huang Y; Xie Q; Lin S; Li L; Li J;
    Gut; 2018 Dec; 67(12):2181-2191. PubMed ID: 28928275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma.
    Steel LF; Shumpert D; Trotter M; Seeholzer SH; Evans AA; London WT; Dwek R; Block TM
    Proteomics; 2003 May; 3(5):601-9. PubMed ID: 12748940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.
    Gressner OA; Fang M; Li H; Lu LG; Gressner AM; Gao CF
    Clin Chim Acta; 2013 Jun; 421():126-31. PubMed ID: 23501329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection.
    Zhao L; Li T; Wang Y; Pan Y; Ning H; Hui X; Xie H; Wang J; Han Y; Liu Z; Fan D
    Int J Clin Pract; 2008 Jul; 62(7):1056-62. PubMed ID: 17537188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B.
    Xu B; Lin L; Xu G; Zhuang Y; Guo Q; Liu Y; Wang H; Zhou X; Wu S; Bao S; Cai W; Xie Q
    J Gastroenterol Hepatol; 2015 Feb; 30(2):372-8. PubMed ID: 25167956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic hepatitis B virus infection in Asian countries.
    Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement 5a is an indicator of significant fibrosis and earlier cirrhosis in patients chronically infected with hepatitis B virus.
    Deng Y; Zhao H; Zhou J; Yan L; Wang G;
    Infection; 2017 Feb; 45(1):75-81. PubMed ID: 27605044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.
    Li N; Long Y; Fan X; Liu H; Li C; Chen L; Wang Z
    J Exp Clin Cancer Res; 2009 Aug; 28(1):122. PubMed ID: 19715608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.
    Gangadharan B; Bapat M; Rossa J; Antrobus R; Chittenden D; Kampa B; Barnes E; Klenerman P; Dwek RA; Zitzmann N
    PLoS One; 2012; 7(6):e39603. PubMed ID: 22761838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features of acute hepatitis E super-infections on chronic hepatitis B.
    Chen C; Zhang SY; Zhang DD; Li XY; Zhang YL; Li WX; Yan JJ; Wang M; Xun JN; Lu C; Ling Y; Huang YX; Chen L
    World J Gastroenterol; 2016 Dec; 22(47):10388-10397. PubMed ID: 28058019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma myeloperoxidase activity and apolipoprotein A-1 expression in chronic hepatitis B patients.
    Mohamadkhani A; Jazii FR; Sayehmiri K; Jafari-Nejad S; Montaser-Kouhsari L; Poustchi H; Montazeri G
    Arch Iran Med; 2011 Jul; 14(4):254-8. PubMed ID: 21726101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential circulating biomarkers of circulating chemokines CCL5, MIP-1β and HA as for early detection of cirrhosis related to chronic HBV (hepatitis B virus) infection.
    Hu L; Zhu Y; Zhang J; Chen W; Li Z; Li L; Zhang L; Cao D
    BMC Infect Dis; 2019 Jun; 19(1):523. PubMed ID: 31200663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.